The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based study

BACKGROUND: Beta-blockers can reduce recurrence, metastasis, and mortality in various cancers. In this study, we investigated the effect of propranolol, a non-selective beta-blocker on overall survival (OS) in unresectable/metastatic hepatocellular carcinoma (HCC) and on recurrence-free survival (RF...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Chang, Ping-Ying, Chung, Chi-Hsiang, Chang, Wei-Chou, Lin, Chun-Shu, Lin, Hsuan-Hwai, Dai, Ming-Shen, Ho, Ching-Liang, Chien, Wu-Chien
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534323/
https://ncbi.nlm.nih.gov/pubmed/31125347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0216828
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados